Literature DB >> 19912140

Influenza B-associated rhabdomyolysis in Taiwanese children.

C-T Wu1, S-H Hsia, J-L Huang.   

Abstract

AIM: Influenza B-associated rhabdomyolysis (IBAR) is an infrequent and little-known complication of influenza B virus infection in children. Diagnosis is usually made based on clinical history, the presence of influenza in the community and detection of virus in nasopharyngeal specimens. The aim of this study was to describe the clinical and laboratory manifestations, complications and outcomes of IBAR in Taiwanese children.
METHODS: A retrospective analysis was conducted in patients aged < 17 years who had been diagnosed with IBAR at a university children's hospital in North Taiwan during 2000-2007. All children enrolled in the study had presented with rhabdomyolysis associated with laboratory-confirmed influenza B infections. Demographic data, clinical manifestations, complications and outcomes were included in the analysis.
RESULTS: Overall, 24 IBAR cases were analysed. IBAR typically occurred in school-aged children with a 7:3 male:female ratio. The mean age was 7.2 ± 1.9 years. Nearly 63% of cases occurred between the ages of 6 and 9 years. The median interval between the onset of influenza and onset of IBAR was 3.4 days (range, 1-14). The calf muscles were involved in all cases. Laboratory tests indicated a mean initial blood creatine kinase of 4212 U/L. The median time to clinical recovery was 5 days (range 1-24). No patient had renal failure. IBAR tends to occur mainly in winter and spring during influenza B outbreaks. IBAR sometimes induces some complications, and early detection and careful medical treatment are necessary.
CONCLUSION: The results of this study indicate that outcomes of IBAR are good with proper medical care.
© 2009 The Author(s)/Journal Compilation © 2009 Foundation Acta Paediatrica.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19912140     DOI: 10.1111/j.1651-2227.2009.01595.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  8 in total

1.  Clinical spectrum of rhabdomyolysis presented to pediatric emergency department.

Authors:  Chun-Yu Chen; Yan-Ren Lin; Lu-Lu Zhao; Wen-Chieh Yang; Yu-Jun Chang; Kang-Hsi Wu; Han-Ping Wu
Journal:  BMC Pediatr       Date:  2013-09-03       Impact factor: 2.125

2.  Genetic characterisation of influenza B viruses detected in Singapore, 2004 to 2009.

Authors:  Muhammad Raihan Jumat; Richard J Sugrue; Boon-Huan Tan
Journal:  BMC Res Notes       Date:  2014-12-01

3.  Epidemiological and Virological Characterization of Influenza B Virus Infections.

Authors:  Sivan Sharabi; Yaron Drori; Michal Micheli; Nehemya Friedman; Sara Orzitzer; Ravit Bassal; Aharona Glatman-Freedman; Tamar Shohat; Ella Mendelson; Musa Hindiyeh; Michal Mandelboim
Journal:  PLoS One       Date:  2016-08-17       Impact factor: 3.240

4.  Uncomplicated Cystitis in an Adult Male Following Influenza B Virus Infection.

Authors:  Robert J Allen; Marios Koutsakos; Aeron C Hurt; Katherine Kedzierska
Journal:  Am J Case Rep       Date:  2017-02-22

5.  Molecular and biochemical characterization of the NS1 protein of non-cultured influenza B virus strains circulating in Singapore.

Authors:  Muhammad Raihan Jumat; Puisan Wong; Raphael Tze Chuen Lee; Sebastian Maurer-Stroh; Boon Huan Tan; Richard J Sugrue
Journal:  Microb Genom       Date:  2016-08-25

6.  CT-based radiomic nomogram for predicting the severity of patients with COVID-19.

Authors:  Hengfeng Shi; Zhihua Xu; Weiqun Ao; Jian Wang; Guohua Cheng; Hongli Ji; Linyang He; Juan Zhu; Hanjin Hu; Zongyu Xie
Journal:  Eur J Med Res       Date:  2022-01-25       Impact factor: 2.175

Review 7.  Vitamins C and D and COVID-19 Susceptibility, Severity and Progression: An Evidence Based Systematic Review.

Authors:  Filippo Migliorini; Raju Vaishya; Jörg Eschweiler; Francesco Oliva; Frank Hildebrand; Nicola Maffulli
Journal:  Medicina (Kaunas)       Date:  2022-07-15       Impact factor: 2.948

8.  Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease.

Authors:  Wei Liu; Zhao-Wu Tao; Lei Wang; Ming-Li Yuan; Kui Liu; Ling Zhou; Shuang Wei; Yan Deng; Jing Liu; Hui-Guo Liu; Ming Yang; Yi Hu
Journal:  Chin Med J (Engl)       Date:  2020-05-05       Impact factor: 2.628

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.